http://researchonline.federation.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:5334 Wed 27 Nov 2024 16:57:52 AEDT ]]> Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10852 Wed 07 Apr 2021 13:56:13 AEST ]]> Developing NKT cells need their (E) protein http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:7266 Wed 07 Apr 2021 13:46:44 AEST ]]> Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:7268 Wed 07 Apr 2021 13:46:44 AEST ]]> Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:6744 Wed 07 Apr 2021 13:46:18 AEST ]]> Ex-vivo analysis of human Natural Killer T cells demonstrates heterogeneity between tissues and within established CD4+ and CD4- subsets http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:4932 Wed 07 Apr 2021 13:44:31 AEST ]]>